Please use this identifier to cite or link to this item: doi:10.22028/D291-30780
Title: Studies on the in vitro and in vivo metabolism of the synthetic opioids U-51754, U-47931E, and methoxyacetylfentanyl using hyphenated high-resolution mass spectrometry
Author(s): Nordmeier, Frederike
Richter, Lilian H. J.
Schmidt, Peter H.
Schaefer, Nadine
Meyer, Markus
Language: English
Title: Scientific Reports
Volume: 9
Issue: 1
Publisher/Platform: SpringerNature
Year of Publication: 2019
Free key words: Bioanalytical chemistry
Mass spectrometry
Population screening
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: New Synthetic Opioids (NSOs) are one class of New Psychoactive Substances (NPS) enjoying increasing popularity in Europe. Data on their toxicological or metabolic properties have not yet been published for most of them. In this context, the metabolic fate of three NSOs, namely, trans-3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzenacetamide (U-51754), trans-4-bromo-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide (U-47931E), and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide (methoxyacetylfentanyl), was elucidated by liquid chromatography high-resolution mass spectrometry after pooled human S9 fraction (phS9) incubations and in rat urine after oral administration. The following major reactions were observed: demethylation of the amine moiety for U-51754 and U-47931E, N-hydroxylation of the hexyl ring, and combinations thereof. N-dealkylation, O-demethylation, and hydroxylation at the alkyl part for methoxyacetylfentanyl. Except for U-47931E, parent compounds could only be found in trace amounts in rat urine. Therefore, urinary markers should preferably be metabolites, namely, the N-demethyl-hydroxy and the hydroxy metabolite for U-51754, the N-demethylated metabolite for U-47931E, and the N-dealkylated metabolite as well as the O-demethylated one for methoxyacetylfentanyl. In general, metabolite formation was comparable in vitro and in vivo, but fewer metabolites, particularly those after multiple reaction steps and phase II conjugates, were found in phS9. These results were consistent with those of comparable compounds obtained from human liver microsomes, human hepatocytes, and/or human case studies.
DOI of the first publication: 10.1038/s41598-019-50196-y
Link to this record: urn:nbn:de:bsz:291--ds-307809
hdl:20.500.11880/29048
http://dx.doi.org/10.22028/D291-30780
ISSN: 2045-2322
Date of registration: 24-Apr-2020
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Prof. Dr. Markus Meyer
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s41598-019-50196-y.pdfStudies on the in vitro and in vivo metabolism2,18 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons